title: Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion.
authors.affiliation: Pediatric Branch, National Cancer Institute, Bethesda, MD 20892.
authors.forename: S L
authors.initials: SL
authors.lastname: Berg
authors.forename: K H
authors.initials: KH
authors.lastname: Cowan
authors.forename: F M
authors.initials: FM
authors.lastname: Balis
authors.forename: J S
authors.initials: JS
authors.lastname: Fisherman
authors.forename: A M
authors.initials: AM
authors.lastname: Denicoff
authors.forename: M
authors.initials: M
authors.lastname: Hillig
authors.forename: D G
authors.initials: DG
authors.lastname: Poplack
authors.forename: J A
authors.initials: JA
authors.lastname: O'Shaughnessy
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000097:blood / Q000493:pharmacokinetics*; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy; D004317:Doxorubicin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*
chemical_list: D004317:Doxorubicin; D017239:Paclitaxel